Periconceptional vitamin useand leukemia risk in children with Down syndrome: a Children's Oncology Group study

Julie A Ross1, Cindy K Blair, Andrew F Olshan

  • 1Division of Pediatric Epidemiology and Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota 55455, USA. ross@epi.umn.edu

Cancer
|June 14, 2005
PubMed

Insights

Periconceptional vitamin supplementation may reduce the risk of leukemia in children with Down syndrome (DS). This protective effect was observed for acute lymphoblastic leukemia (ALL) but not acute myeloid leukemia (AML).

Area of Science:

  • Pediatric Oncology
  • Nutritional Epidemiology
  • Genetics and Cancer

Background:

  • Children with Down syndrome (DS) have a significantly higher risk of leukemia.
  • Periconceptional vitamin supplementation is known to reduce neural tube defects and may lower the risk of certain childhood cancers.

Purpose of the Study:

  • To investigate whether periconceptional vitamin supplementation reduces leukemia risk in children with Down syndrome.

Main Methods:

  • A case-control study involving 158 children with DS and acute leukemia and 173 children with DS alone.
  • Mothers of cases and controls were interviewed about periconceptional vitamin supplement use.

Main Results:

  • Periconceptional vitamin supplementation was associated with a reduced risk of leukemia in children with DS (OR=0.63).
  • The reduced risk was significant for acute lymphoblastic leukemia (ALL) (OR=0.51) but not for acute myeloid leukemia (AML) (OR=0.92).
  • Supplementation after pregnancy knowledge increased leukemia risk (OR=1.61).

Conclusions:

  • Periconceptional vitamin use may offer protection against certain childhood cancers, including leukemia in children with DS.
  • These findings support existing evidence on the protective role of periconceptional vitamins in cancer development.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...